Literature DB >> 5480850

Effects of glucagon on adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in human plasma and urine.

A E Broadus, N I Kaminsky, R C Northcutt, J G Hardman, E W Sutherland, G W Liddle.   

Abstract

Glucagon, infused intravenously into fasting, well-hydrated, normal men in doses of 25-200 ng/kg per min, induced up to 30-fold increases in both plasma and urinary cyclic AMP. Cyclic GMP levels were unaffected by glucagon. Simultaneous cyclic AMP and inulin clearance studies demonstrated that the glucagon-induced increase in urinary cyclic AMP was entirely due to glomerular filtration of the elevated plasma levels of the nucleotide. The cyclic AMP response to glucagon was not mediated by parathyroid hormone or epinephrine, and trypsintreated glucagon was completely inactive. The perfused rat liver released cyclic AMP into the perfusate in response to glucagon, indicating that the liver is a possible source of the cyclic AMP entering the extracellular fluids in response to glucagon in vivo.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5480850      PMCID: PMC322724          DOI: 10.1172/JCI106442

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  USE OF LIVER ADENYL CYCLASE FOR ASSAY OF GLUCAGON IN HUMAN GASTRO-INTESTINAL TRACT AND PANCREAS.

Authors:  M H MAKMAN; E W SUTHERLAND
Journal:  Endocrinology       Date:  1964-07       Impact factor: 4.736

2.  [On the diuretic and saluretic effect of glucagon in man].

Authors:  D P MERTZ
Journal:  Z Gesamte Exp Med       Date:  1963

3.  Effects of some hormonal and other factors on the excretion of guanosine 3',5'-monophosphate and adenosine 3',5'-monophosphate in rat urine.

Authors:  J G Hardman; J W Davis; E W Sutherland
Journal:  J Biol Chem       Date:  1969-12-10       Impact factor: 5.157

4.  Effects of lipolytic and antilipolytic substances on adenosine 3',5'-monophosphate levels in isolated fat cells.

Authors:  R W Butcher; C E Baird; E W Sutherland
Journal:  J Biol Chem       Date:  1968-04-25       Impact factor: 5.157

5.  Parathyroid function and the renal excretion of 3'5'-adenylic acid.

Authors:  L R Chase; G D Aurbach
Journal:  Proc Natl Acad Sci U S A       Date:  1967-08       Impact factor: 11.205

6.  Measurement of guanosine 3',5'-monophosphate and other cyclic nucleotides. Variations in urinary excretion with hormonal state of the rat.

Authors:  J G Hardman; J W Davis; E W Sutherland
Journal:  J Biol Chem       Date:  1966-10-25       Impact factor: 5.157

7.  Organophosphates of urine, including adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate.

Authors:  T D Price; D F Ashman; M M Melicow
Journal:  Biochim Biophys Acta       Date:  1967-05-30

8.  Renal adenyl cyclase: anatomically separate sites for parathyroid hormone and vasopressin.

Authors:  L R Chase; G D Aurbach
Journal:  Science       Date:  1968-02-02       Impact factor: 47.728

9.  Adenosine 3',5'-monophosphate in biological materials. II. The measurement of adenosine 3',5'-monophosphate in tissues and the role of the cyclic nucleotide in the lipolytic response of fat to epinephrine.

Authors:  R W Butcher; R J Ho; H C Meng; E W Sutherland
Journal:  J Biol Chem       Date:  1965-11       Impact factor: 5.157

10.  Kinetic parameters and renal clearances of plasma adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in man.

Authors:  A E Broadus; N I Kaminsky; J G Hardman; E W Sutherland; G W Liddle
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

View more
  38 in total

1.  Urinary excretion of cyclic AMP in bacterial infections.

Authors:  W J Sibbald; V M Sardesai; A Short; R F Wilson
Journal:  Intensive Care Med       Date:  1979-05       Impact factor: 17.440

2.  Efflux of cyclic AMP from resealed erythrocyte ghosts is not enhanced by Hepes.

Authors:  C H Sear; M J Duffy
Journal:  Experientia       Date:  1975-08-15

3.  Effect of administration of the fructose on the glycogenolytic action of glucagon. An investigation of the pathogeny of hereditary fructose intolerance.

Authors:  G Van Den Berghe; L Hue; H G Hers
Journal:  Biochem J       Date:  1973-06       Impact factor: 3.857

4.  Plasma cyclic AMP levels during a secretin-caerulein pancreatic function test in liver and pancreatic disease.

Authors:  M Adler; P Robberecht; M G Poitevin; J Christophe
Journal:  Gut       Date:  1978-03       Impact factor: 23.059

5.  The extracellular cAMP-adenosine pathway regulates expression of renal D1 dopamine receptors in diabetic rats.

Authors:  Eldo V Kuzhikandathil; Leslie Clark; Ying Li
Journal:  J Biol Chem       Date:  2011-07-29       Impact factor: 5.157

Review 6.  Application of the Sousa (John Phillip) principles to medical research: the role of cyclic nucleotides in hormone and drug action.

Authors:  E D Bransome
Journal:  Trans Am Clin Climatol Assoc       Date:  1978

7.  Cyclic AMP metabolism and adenylate cyclase concentration in patients with advanced hepatic cirrhosis.

Authors:  A Francavilla; A F Jones; T E Starzl
Journal:  Gastroenterology       Date:  1978-12       Impact factor: 22.682

8.  Effects of glucagon on lipolysis and ketogenesis in normal and diabetic men.

Authors:  J E Liljenquist; J D Bomboy; S B Lewis; B C Sinclair-Smith; P W Felts; W W Lacy; O B Crofford; G W Liddle
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

9.  Anomalous plasma cyclic AMP responses to glucagon in patients with liver disease.

Authors:  H Maekubo; T Matsushima; F Okada; M Honma; M Ui
Journal:  Dig Dis Sci       Date:  1980-09       Impact factor: 3.199

10.  Cyclic adenosine monophosphate and human gastric acid secretion.

Authors:  R H Bower; J Sode; W H Lipshutz
Journal:  Am J Dig Dis       Date:  1977-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.